ViroCell Biologics is a Contract Development and Manufacturing Organization (CDMO), which is a company that provides services such as product development and manufacturing to other companies in the biotech industry. ViroCell specializes in the design and manufacture of lenti and gamma-retro viral vectors, which are tools used in cell and gene therapies. These therapies are a type of treatment that involve altering the genes inside your body's cells to treat or stop disease.

ViroCell's clients are primarily companies in the biotech industry that are developing new cell and gene therapies. These companies outsource the production of viral vectors to ViroCell, which has over 20 years of experience and has manufactured approximately 200 vectors.

ViroCell operates in the biotech industry, specifically in the cell and gene therapy market. This is a rapidly growing market due to the increasing number of diseases that can be treated with these therapies.

ViroCell's business model is based on providing a service to other companies. They make money by charging these companies for the design and manufacture of the viral vectors needed for their therapies.

ViroCell's goal is to accelerate the development of new therapies by providing high-quality, reliable manufacturing services. They aim to help their clients get their therapies to clinical trials faster, which could lead to new treatments for diseases and progress in the field of medicine.

Keywords: Biotech Industry, Contract Development and Manufacturing Organization (CDMO), Viral Vectors, Cell Therapy, Gene Therapy, Outsourcing, Service Provider, Clinical Trials, Disease Treatment, Innovation.